![Nigel Keith Davis](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nigel Keith Davis
Directeur/Bestuurslid bij Pronec Ltd.
Profiel
Nigel Keith Davis is currently a Director at Pronec Ltd.
He previously worked as the Chief Business Officer at Cambridge Theranostics Ltd.
Actieve functies van Nigel Keith Davis
Bedrijven | Functie | Begin |
---|---|---|
Pronec Ltd.
![]() Pronec Ltd. Miscellaneous Commercial ServicesCommercial Services Pronec Ltd. engages in the research and experimental development on biotechnology. The company was founded on September 14, 2015 and is headquartered in Wirral, the United Kingdom. | Directeur/Bestuurslid | 11-12-2015 |
Eerdere bekende functies van Nigel Keith Davis
Bedrijven | Functie | Einde |
---|---|---|
Cambridge Theranostics Ltd.
![]() Cambridge Theranostics Ltd. Pharmaceuticals: GenericHealth Technology Cambridge Theranostics (CTL) was founded in 2002 as a spin-out from Cambridge University, following the discovery of ALOA (Atherogenic Lipid-Oxidising Antibodies) by its founder Dr. Petyaev. It is privately funded. The Company continues to have a very strong research focus and now owns 10 granted patents in Europe, U.S.A, Eurasia and Japan the US, with a further 18 applications pending. They also conduct clinical studies with their partners in Europe, U.S. and Russia. CTL develops specially formulated supplements to provide the correct doses of nutrients in a form that is effective. Its scientists investigate the mechanisms by which nutrients prevent disease and develop highly effective formulations. Together with their clinical partners, they confirm that the nutrient reaches the correct part of the body and is active. | Corporate Officer/Principal | 18-12-2012 |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Cambridge Theranostics Ltd.
![]() Cambridge Theranostics Ltd. Pharmaceuticals: GenericHealth Technology Cambridge Theranostics (CTL) was founded in 2002 as a spin-out from Cambridge University, following the discovery of ALOA (Atherogenic Lipid-Oxidising Antibodies) by its founder Dr. Petyaev. It is privately funded. The Company continues to have a very strong research focus and now owns 10 granted patents in Europe, U.S.A, Eurasia and Japan the US, with a further 18 applications pending. They also conduct clinical studies with their partners in Europe, U.S. and Russia. CTL develops specially formulated supplements to provide the correct doses of nutrients in a form that is effective. Its scientists investigate the mechanisms by which nutrients prevent disease and develop highly effective formulations. Together with their clinical partners, they confirm that the nutrient reaches the correct part of the body and is active. | Health Technology |
Pronec Ltd.
![]() Pronec Ltd. Miscellaneous Commercial ServicesCommercial Services Pronec Ltd. engages in the research and experimental development on biotechnology. The company was founded on September 14, 2015 and is headquartered in Wirral, the United Kingdom. | Commercial Services |